-+ 0.00%
-+ 0.00%
-+ 0.00%

DIAGONAL THERAPEUTICS ANNOUNCES OVERSUBSCRIBED $125 MILLION SERIES B FINANCING TO ADVANCE CLINICAL DEVELOPMENT OF DISEASE-MODIFYING, CLUSTERING ANTIBODY PIPELINE

路透·01/08/2026 11:30:30

登录查看新闻详情